Growth-Regulatory Effects of Sensory Neuropeptides, Epidermal Growth Factor, Insulin, and Somatostatin on the Non-Transformed Intestinal Epithelial Cell Line IEC-6 and the Colon Cancer Cell Line HT 29

References

• Ouastler H, Sherman F G. Cell population kinetics in the intestinal epithelium of the mouse. Exp Cell Res 1959; 17: 420–38
   PubMedGoogle Scholar
• Klein R M, McKenzie J C. The role of cell renewal in ontogeny of the intestine. II. Regulation of cell proliferation in adult, fetal and neonatal intestine. J Pediatr Gastroenterol Nutr 1983; 2: 24–28
   Google Scholar
• Quaroni A, May R J. Establishment and characterization of intestinal epithelial cell cultures. Met Cell Biol 1980; B: 403–27
   Google Scholar
• Barnard J A, Beauchamp R D, Coffey R J, Moses H L. Regulation of intestinal epithelial cell growth by transforming growth factor type β. Proc Natl Acad Sci 1989; 86: 1578–82
   PubMed Web of Science ®Google Scholar
• Kurokowa M, Lynch K, Podolsky D K. Effects of growth factors on an intestinal epithelial cell line: transforming growth factor β inhibits proliferation and stimulates differentiation. Biochem Biophys Res Commun 1987; 142: 775–82
   PubMed Web of Science ®Google Scholar
• Conteas C N, Majumdar P N. The effects of gastrin, epidermal growth factor, and somatostatin on DNA synthesis in a small intestinal crypt cell line (IEC-6). Proc Soc Exp Biol Med 1989; 184: 307–11
   Google Scholar
• Conteas C N, McMorrow B, Luk G D. Modulation of epidermal growth factor induced cell proliferation and receptor binding by insulin in cultured intestinal epithelial cells. Biochem Biophys Res Commun 1989; 161: 414–9
   PubMed Web of Science ®Google Scholar
• Fehér E, Göres T, Burnstock G. Somatostatin immunoreactive nerve fibers in close association with capillaries in the small intestine. Peptides 1989; 10: 945–9
   PubMedGoogle Scholar
• Palmer Smith J, Solomon T E. Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer. Gastroenterology 1988; 95: 1541–8
   PubMed Web of Science ®Google Scholar
• Goodland R A, Gregory H, Wright N A. Is polyamine synthesis involved in the proliferative response of the intestinal epithelium to urogastrone-epidermal growth factor?. Clin Sci 1989; 76: 595–8
   Google Scholar
• Lehy T, Dubrasquet M, Bonfils S. Effect of somatostatin on normal and gastric-stimulated cell proliferation in the gastric and intestinal mucosae of the rat. Digestion 1979; 19: 99–109
   PubMed Web of Science ®Google Scholar
• Rivard N, Guan D, Turkelson C, Petitclerc D, Solomon T, Morisset J. Negative control by Sandostatin on pancreatic and duodenal growth: a possible implication of insulin-like growth factor-1. Regul Pept 1991; 34: 13–23
   PubMedGoogle Scholar
• Blay J, Brown K D. Contradistinctive growth responses of cultured rat intestinal epithelial cells to epidermal growth factor depending on cell population density. J Cell Physiol 1986; 129: 343–6
   PubMedGoogle Scholar
• Tsuzaki S, Moses A C. Somatostatin inhibits deoxyribonucleic acid synthesis induced by both thyrotropin and insulin-like growth factor-1 in FRTL5 cells. Endocrinology 1990; 126: 3131–8
   PubMedGoogle Scholar
• Nelson Cremin J. M, Murphy R F. Synthesis of somatostatin by breast cancer cells and their inhibition by exogenous somatostatin and Sandostatin. Br J Cancer 1989; 59: 739–42
   PubMedGoogle Scholar
• Dorflinger L J, Schonbrunn A. Somatostatin inhibits vasoactive intestinal peptide stimulated cyclic adenosine monophosphate accumulation in GH pituitary cells. Endocrinology 1983; 113: 1541–50
   PubMedGoogle Scholar
• Liebow C, Reilly C, Serrano R M, Schally A V. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc Natl Acad Sci 1989; 86: 2003–7
   PubMed Web of Science ®Google Scholar
• Arilla E, Lopez-Ruiz P, Guijarro L G, Prieto J C, Gomez-Pan A, Hirst B. Characterization of somatostatin binding sites in cytosolic fraction of rat intestinal mucosa. Biochem Biophys Acta 1984; 802: 203–8
   PubMed Web of Science ®Google Scholar
• Nilsson J, von Euler A M, Dalsgaard C-J. Stimulation of connective tissue cell growth by substance P and substance K. Nature 1985; 315: 61–3
   PubMed Web of Science ®Google Scholar
• Tanaka T, Danno K, Ikai K, Imamura S. Effects of substance P and substance K on the growth of cultured keratinoevtes. J Invest Dermatol 1988; 90: 399–401
   PubMed Web of Science ®Google Scholar
• Ziche M, Morbidelli M P, Pacini M, Geppetti P, Alessandri G, Maggi C A. Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res 1990; 40: 264–78
   PubMed Web of Science ®Google Scholar
• Hilaire R J, Gospodarowicz D, Kim Y S. Epidermal growth factor: effect on growth of a colon adenocarcinoma cell line. Gastroenterology 1980; 78: 1271
   Google Scholar
• Cezard J-P, Forgue-Lafitte M-E, Chamblier M-C, Rosselin G E. Growth-promoting effect, biological activity, and binding of insulin in human intestinal cancer cells in culture. Cancer Res 1981; 41: 1148–53
   PubMedGoogle Scholar
• Anzano M A, Rieman D, Prichett W, Bowen-Pope D F, Greig R. Growth factor production bv human colon carcinoma cell lines. Cancer Res 1989; 49: 2894–904
   PubMedGoogle Scholar
• Forgue-Lafitte M-E, Coudray Bréant A-M., McSter B. J. Proliferation of the human colon carcinoma cell line HT 29: autocrine growth and deregulated expression of c-myc oncogene. Cancer Res 1989; 49: 6566–71
   PubMed Web of Science ®Google Scholar
• Bepler G, Zeymer Mahmoud U. S., et al. Substance P analogues function as bombesin receptor antagonists and inhibit small cell lung cancer clonal growth. Peptides 1989; 9: 1367–72
   Google Scholar
• Iishi H, Tatsuta M, Baba M, Okuda S, Taniguchi H. Enhancement by vasoactive intestinal peptide of experimental carcinogenesis induced by azoxymethane in rat colon. Cancer Res 1987; 47: 4890–3
   PubMedGoogle Scholar
• Hoosein N M, Black B E, Brattain D, Brattain E. MG. Promotion of differentiation in human colon carcinoma cells by vasoactive intestinal polypeptide. Regul Peptides 1989; 24: 15–26
   PubMedGoogle Scholar
• Garnet L, Cazenave Y, Trocheris V., Denis-Pouxviel C, Murat J-C. Involvement of ornithine decarboxylase in the control of proliferation of the HT29 human colon cancer cell line. Effect of vasoactive intestinal peptide on enzyme activity. Int J Cancer 1991; 47: 633–638
   PubMedGoogle Scholar
• Chastre E, Emami S, Gespach C. VIP receptor activity during HT 29–18 cell differentiation and rat intestinal development. Peptides 1986; 7(Suppl 1)113–9
   PubMedGoogle Scholar